Functional Selectivity and Classical Concepts of Quantitative Pharmacology

@article{Urban2007FunctionalSA,
  title={Functional Selectivity and Classical Concepts of Quantitative Pharmacology},
  author={Jonathan D. Urban and William P Clarke and Mark von Zastrow and David E. Nichols and Brian K. Kobilka and Harel Weinstein and Jonathan A. Javitch and Bryan L. Roth and Arthur Christopoulos and Patrick M. Sexton and Keith J. Miller and Michael Spedding and Richard B. Mailman},
  journal={Journal of Pharmacology and Experimental Therapeutics},
  year={2007},
  volume={320},
  pages={1 - 13}
}
  • J. Urban, W. Clarke, +10 authors R. Mailman
  • Published 1 January 2007
  • Medicine, Biology
  • Journal of Pharmacology and Experimental Therapeutics
The concept of intrinsic efficacy has been enshrined in pharmacology for half of a century, yet recent data have revealed that many ligands can differentially activate signaling pathways mediated via a single G protein-coupled receptor in a manner that challenges the traditional definition of intrinsic efficacy. Some terms for this phenomenon include functional selectivity, agonist-directed trafficking, and biased agonism. At the extreme, functionally selective ligands may be both agonists and… Expand
Functional Selectivity at Cannabinoid Receptors.
TLDR
A recent extensive characterization of the molecular pharmacology of CB2 agonists identified marked differences in the ability of certain agonists to activate distinct signaling pathways (cAMP accumulation, ERK phosphorylation, GIRK activation, GTPγS binding, and β-arrestin recruitment) and to cause off-target effects, exemplifying the need to evaluate functional selectivity in agonist drug development. Expand
Ligand functional selectivity and quantitative pharmacology at G protein-coupled receptors
TLDR
A standardization of this nomenclature is proposed as an essential step to both simplify and clarify the language used among researchers to facilitate future collaboration and discovery of these important therapeutic targets. Expand
Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity
  • K. Berg, W. Clarke
  • Chemistry, Medicine
  • The international journal of neuropsychopharmacology
  • 2018
Abstract Constitutive receptor activity/inverse agonism and functional selectivity/biased agonism are 2 concepts in contemporary pharmacology that have major implications for the use of drugs inExpand
Functional Selectivity at Dopamine Receptors
This chapter reviews functional selectivity at dopamine receptors with emphasis on ligands for both D2 and D1 receptors. The signaling mechanisms for both the D1 and D2 receptors are reviewed, and weExpand
A study of functional selectivity at the cannabinoid type 1 receptor
TLDR
This thesis investigates ligand-selective functional selectivity at the cannabinoid CB1 receptor both endogenously and exogenously expressed in a variety of cell lines and results suggest it may be possible to produce drugs which selectively activate signalling pathways linked to therapeutic benefits, while minimising activation of those associated with unwanted side effects. Expand
Functional Selectivity in Adrenergic and Angiotensin Signaling Systems
TLDR
The concept of “biased signaling” through β-arrestin mediated pathways, the affect of ligand/receptor modification on such biased agonism, and the implications of functional selectivity for the development of the next generation of β-blockers and angiotensin receptor blockers are highlighted. Expand
Missing Links: Mechanisms of Protean Agonism
  • R. Neubig
  • Chemistry, Medicine
  • Molecular Pharmacology
  • 2007
TLDR
Two articles in recent issues of Molecular Pharmacology further solidify the concepts of functional selectivity and protean agonism and begin to define the first postreceptor step in actions of proteAn agonist ligands. Expand
Functional Selectivity at Opioid Receptors
Opiate drugs are among the most effective analgesics available but their clinical use is restricted by tolerance, physical dependence, respiratory depression, nausea, and constipation. As a class,Expand
GPCR functional selectivity has therapeutic impact.
  • R. Mailman
  • Biology, Medicine
  • Trends in pharmacological sciences
  • 2007
TLDR
Data obtained with experimental compounds that are functionally selective at the dopamine D2L receptor in vitro provide support for the hypothesis that compounds with functionally selective properties in vitro are likely to have novel actions in vivo, opening doors to new avenues of drug discovery. Expand
Structure-functional selectivity relationship studies of β-arrestin-biased dopamine D₂ receptor agonists.
TLDR
The first comprehensive SFSR studies focused on exploring four regions of the aripiprazole scaffold resulted in the discovery of these β-arrestin-biased D(2)R agonists, providing a successful proof-of-concept for how functionally selective ligands can be discovered. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 144 REFERENCES
The elusive nature of intrinsic efficacy.
TLDR
Several reasons why the claim that intrinsic efficacy is a ligand-dependent parameter should be questioned are discussed, and the possible impact of these findings are discussed. Expand
Functionally Different Agonists Induce Distinct Conformations in the G Protein Coupling Domain of the β2Adrenergic Receptor*
TLDR
Monitoring ligand-induced conformational changes in the G protein-coupling domain of the β2 adrenergic receptor provides new insight into the structural consequence of antagonist binding and the basis of agonism and partial agonism. Expand
Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus.
TLDR
Concentration-response curves to 5-HT2C agonists were fit well by a three-state model of receptor activation, suggesting that two active receptor states may be sufficient to explain pathway-dependent agonist efficacy. Expand
Hallucinogen actions on 5-HT receptors reveal distinct mechanisms of activation and signaling by G protein-coupled receptors
TLDR
It is shown how a combined computational and experimental approach can reveal specific modes of receptor activation underlying the difference in properties of hallucinogens compared with nonhallucinogenic congeners. Expand
μ-Opioid Receptors: Ligand-Dependent Activation of Potassium Conductance, Desensitization, and Internalization
TLDR
The results suggest that agonist efficacy is not necessarily a predictor of the ability to cause MOR desensitization or endocytosis, and identification and characterization of the biophysical properties of agonists that favor desens itization and internalization of receptors will lead to a better understanding of opioid signaling. Expand
Aripiprazole has Functionally Selective Actions at Dopamine D2 Receptor-Mediated Signaling Pathways
TLDR
The results are consistent with the hypothesis that aripiprazole is a functionally selective D2 ligand rather than a simple partial agonist, and may be useful in understanding the novel clinical actions of this drug. Expand
G Protein-Coupled Receptor Allosterism and Complexing
TLDR
It is proposed that the study of allosteric phenomena will become of progressively greater import to the drug discovery process due to the advent of newer and more sensitive GPCR screening technologies. Expand
Sequential binding of agonists to the beta2 adrenoceptor. Kinetic evidence for intermediate conformational states.
TLDR
A mechanistic model for GPCR activation where contacts between the receptor and structural determinants of the agonist stabilize a succession of conformational states with distinct cellular functions is supported. Expand
The structure and dynamics of GPCR oligomers: a new focus in models of cell-signaling mechanisms and drug design.
TLDR
The development of increasingly accurate dynamic molecular models of G PCR dimers is expected to produce a more complete structural context for understanding the molecular mechanisms of GPCR function, and to aid in drug discovery. Expand
Probing the β2 Adrenoceptor Binding Site with Catechol Reveals Differences in Binding and Activation by Agonists and Partial Agonists*
TLDR
Catechol is used as a molecular probe to identify mechanistic differences between β2AR activation by catecholamine agonists, such as isoproterenol, and by the structurally related non-catechol partial agonist salbutamol, showing unexpected differences in binding and activation by structurally similar agonists and partial agonists. Expand
...
1
2
3
4
5
...